Sign in
4

Changes in Ownership

Telomir Pharmaceuticals, Inc. Filed Acc 0001493152-24-034367

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Whalen Matthew Pratt Director 2024-08-27 Grant or award · Incentive Stock Options (right to buy) +25,000 25,000 D
Loading xslF345X05/ownership.xml…